24 April 2024 - A new targeted drug combination treatment, described as a ‘step-change in care’ for children and young ...
15 March 2024 - Pharmac has decided to keep Rule 8.1b, which allows medicines for treating children with cancer to ...
16 January 2024 - Fenfluramine costs more than $3,000 a month and is not approved by Health Canada. ...
8 December 2023 - Little Jack Roche was five weeks old when diagnosed with cystic fibrosis. The medication that could help ...
1 December 2023 - Two small RCTs with children of different ages together make it possible to make one statement: the ...
29 November 2023 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
9 November 2023 - Paediatricians and neonatal experts are pleading with PHARMAC to rethink its decision to stop funding a ...
23 October 2023 - The Australian Government is giving more families access to life changing gene therapy for spinal muscular atrophy ...
23 October 2023 - On 1 November 2023, changes will be made to the authority requirements of the PBS listing ...
5 September 2023 - Families calling for greater access to a medication that helps manage a severe form of epilepsy ...
13 July 2023 - NICE is unable to make a recommendation on the use of semaglutide (Wegovy) on the NHS for ...
15 May 2023 - The Royal Australian College of GPs (RACGP) has welcomed the PBAC's decision to remove limitations requiring ...
12 May 2023 - The independent, expert group advising the Australian Government on PBS medications has reviewed its recommendation to put ...
6 April 2023 - From 1 May 2023, children aged 6 to 11 with cystic fibrosis will have access to ...
5 April 2023 - PHARMAC’s consultation on rule 8.1b of the Pharmaceutical Schedule has now closed. ...